Epicardial vasomotor responses to acetylcholine are not predicted by coronary atherosclerosis as assessed by intracoronary ultrasound. 1995

R A Nishimura, and A Lerman, and J H Chesebro, and D M Ilstrup, and D O Hodge, and S T Higano, and D R Holmes, and A J Tajik
Division of Cardiovascular Diseases and Internal Medicine, Mayo Clinic, Rochester, Minnesota 55905, USA.

OBJECTIVE The purpose of this study was to use intravascular ultrasound to determine the morphologic appearance of the coronary arteries, relating the absence, presence and extent of atherosclerosis to the response of the coronary arteries to acetylcholine infusion. BACKGROUND Endothelial function plays a major role in the pathophysiology of myocardial ischemia and angina pectoris. The response of the coronary arteries to selective infusion of acetylcholine has been used to examine endothelial function, with vasoconstriction occurring in the absence of intact endothelial function. Vasoconstriction to acetylcholine infusion in humans without overt coronary artery disease has been attributed to early atherosclerosis not detected by coronary angiography. METHODS Twenty-nine patients without overt coronary artery disease underwent selective coronary angiography and selective intracoronary infusion of increasing concentrations of acetylcholine (10(-6), 10(-5) and 10(-4) mol/liter), followed by intravascular ultrasound imaging. RESULTS The response of the coronary arteries to acetylcholine infusion was not dependent on the absence or presence of atherosclerotic plaque, as detected by intravascular ultrasound. The percent change in epicardial coronary artery diameter during acetylcholine infusion versus baseline was -14 +/- 28% (mean +/- SD) in the seven patients with no visible atherosclerosis on intravascular ultrasound versus -9 +/- 20% in the 22 patients with visible atherosclerosis on intravascular ultrasound (p = NS, confidence interval -14% to 25%). There was a greater vasoconstrictive response to acetylcholine infusion in patients with risk factors for coronary artery disease than in those without risk factors (p = 0.003). CONCLUSIONS The vasoreactive response to acetylcholine is not necessarily dependent on ultrasound detection of the presence or absence of atherosclerosis.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D003324 Coronary Artery Disease Pathological processes of CORONARY ARTERIES that may derive from a congenital abnormality, atherosclerotic, or non-atherosclerotic cause. Arteriosclerosis, Coronary,Atherosclerosis, Coronary,Coronary Arteriosclerosis,Coronary Atherosclerosis,Left Main Coronary Artery Disease,Left Main Coronary Disease,Left Main Disease,Arterioscleroses, Coronary,Artery Disease, Coronary,Artery Diseases, Coronary,Atheroscleroses, Coronary,Coronary Arterioscleroses,Coronary Artery Diseases,Coronary Atheroscleroses,Left Main Diseases
D003331 Coronary Vessels The veins and arteries of the HEART. Coronary Arteries,Sinus Node Artery,Coronary Veins,Arteries, Coronary,Arteries, Sinus Node,Artery, Coronary,Artery, Sinus Node,Coronary Artery,Coronary Vein,Coronary Vessel,Sinus Node Arteries,Vein, Coronary,Veins, Coronary,Vessel, Coronary,Vessels, Coronary
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000109 Acetylcholine A neurotransmitter found at neuromuscular junctions, autonomic ganglia, parasympathetic effector junctions, a subset of sympathetic effector junctions, and at many sites in the central nervous system. 2-(Acetyloxy)-N,N,N-trimethylethanaminium,Acetilcolina Cusi,Acetylcholine Bromide,Acetylcholine Chloride,Acetylcholine Fluoride,Acetylcholine Hydroxide,Acetylcholine Iodide,Acetylcholine L-Tartrate,Acetylcholine Perchlorate,Acetylcholine Picrate,Acetylcholine Picrate (1:1),Acetylcholine Sulfate (1:1),Bromoacetylcholine,Chloroacetylcholine,Miochol,Acetylcholine L Tartrate,Bromide, Acetylcholine,Cusi, Acetilcolina,Fluoride, Acetylcholine,Hydroxide, Acetylcholine,Iodide, Acetylcholine,L-Tartrate, Acetylcholine,Perchlorate, Acetylcholine
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D014664 Vasodilation The physiological widening of BLOOD VESSELS by relaxing the underlying VASCULAR SMOOTH MUSCLE. Vasodilatation,Vasorelaxation,Vascular Endothelium-Dependent Relaxation,Endothelium-Dependent Relaxation, Vascular,Relaxation, Vascular Endothelium-Dependent,Vascular Endothelium Dependent Relaxation

Related Publications

R A Nishimura, and A Lerman, and J H Chesebro, and D M Ilstrup, and D O Hodge, and S T Higano, and D R Holmes, and A J Tajik
September 2013, Heart (British Cardiac Society),
R A Nishimura, and A Lerman, and J H Chesebro, and D M Ilstrup, and D O Hodge, and S T Higano, and D R Holmes, and A J Tajik
September 2018, Coronary artery disease,
R A Nishimura, and A Lerman, and J H Chesebro, and D M Ilstrup, and D O Hodge, and S T Higano, and D R Holmes, and A J Tajik
February 2005, Herz,
R A Nishimura, and A Lerman, and J H Chesebro, and D M Ilstrup, and D O Hodge, and S T Higano, and D R Holmes, and A J Tajik
October 1992, Circulation research,
R A Nishimura, and A Lerman, and J H Chesebro, and D M Ilstrup, and D O Hodge, and S T Higano, and D R Holmes, and A J Tajik
June 1989, The Journal of clinical investigation,
R A Nishimura, and A Lerman, and J H Chesebro, and D M Ilstrup, and D O Hodge, and S T Higano, and D R Holmes, and A J Tajik
August 2016, Journal of visualized experiments : JoVE,
R A Nishimura, and A Lerman, and J H Chesebro, and D M Ilstrup, and D O Hodge, and S T Higano, and D R Holmes, and A J Tajik
September 1992, Journal of the American College of Cardiology,
R A Nishimura, and A Lerman, and J H Chesebro, and D M Ilstrup, and D O Hodge, and S T Higano, and D R Holmes, and A J Tajik
September 2001, Ugeskrift for laeger,
R A Nishimura, and A Lerman, and J H Chesebro, and D M Ilstrup, and D O Hodge, and S T Higano, and D R Holmes, and A J Tajik
September 1993, Journal of cardiovascular pharmacology,
R A Nishimura, and A Lerman, and J H Chesebro, and D M Ilstrup, and D O Hodge, and S T Higano, and D R Holmes, and A J Tajik
June 2008, Heart (British Cardiac Society),
Copied contents to your clipboard!